BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 1629961)

  • 21. Biochemical evidence of a role for matrix trimerization in HIV-1 envelope glycoprotein incorporation.
    Tedbury PR; Novikova M; Ablan SD; Freed EO
    Proc Natl Acad Sci U S A; 2016 Jan; 113(2):E182-90. PubMed ID: 26711999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging.
    Poon DT; Li G; Aldovini A
    J Virol; 1998 Mar; 72(3):1983-93. PubMed ID: 9499052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tail-interacting protein TIP47 is a connector between Gag and Env and is required for Env incorporation into HIV-1 virions.
    Lopez-Vergès S; Camus G; Blot G; Beauvoir R; Benarous R; Berlioz-Torrent C
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14947-52. PubMed ID: 17003132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro binding of simian immunodeficiency virus matrix protein to the cytoplasmic domain of the envelope glycoprotein.
    Manrique JM; Affranchino JL; González SA
    Virology; 2008 May; 374(2):273-9. PubMed ID: 18255119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
    Liao WH; Wang CT
    Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein.
    Dorfman T; Mammano F; Haseltine WA; Göttlinger HG
    J Virol; 1994 Mar; 68(3):1689-96. PubMed ID: 8107229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The C terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps of the virus life cycle.
    Yu X; Yu QC; Lee TH; Essex M
    J Virol; 1992 Sep; 66(9):5667-70. PubMed ID: 1501299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant.
    Wang CT; Zhang Y; McDermott J; Barklis E
    J Virol; 1993 Dec; 67(12):7067-76. PubMed ID: 7693966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.
    Sova P; Volsky DJ; Wang L; Chao W
    J Virol; 2001 Jun; 75(12):5504-17. PubMed ID: 11356958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway.
    Chazal N; Gay B; Carrière C; Tournier J; Boulanger P
    J Virol; 1995 Jan; 69(1):365-75. PubMed ID: 7983731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.
    Chertova E; Bess JW; Crise BJ; Sowder II RC; Schaden TM; Hilburn JM; Hoxie JA; Benveniste RE; Lifson JD; Henderson LE; Arthur LO
    J Virol; 2002 Jun; 76(11):5315-25. PubMed ID: 11991960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incorporation of human immunodeficiency virus type 1 Gag proteins into murine leukemia virus virions.
    Deminie CA; Emerman M
    J Virol; 1993 Nov; 67(11):6499-506. PubMed ID: 8411353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations of the human immunodeficiency virus type 1 p6Gag domain result in reduced retention of Pol proteins during virus assembly.
    Yu XF; Dawson L; Tian CJ; Flexner C; Dettenhofer M
    J Virol; 1998 Apr; 72(4):3412-7. PubMed ID: 9525672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles.
    Lavallée C; Yao XJ; Ladha A; Göttlinger H; Haseltine WA; Cohen EA
    J Virol; 1994 Mar; 68(3):1926-34. PubMed ID: 8107252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coding sequences upstream of the human immunodeficiency virus type 1 reverse transcriptase domain in Gag-Pol are not essential for incorporation of the Pr160(gag-pol) into virus particles.
    Chiu HC; Yao SY; Wang CT
    J Virol; 2002 Apr; 76(7):3221-31. PubMed ID: 11884546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein.
    Cimarelli A; Luban J
    J Virol; 1999 Jul; 73(7):5388-401. PubMed ID: 10364286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of human immunodeficiency virus type 1 matrix phosphorylation in an early postentry step of virus replication.
    Kaushik R; Ratner L
    J Virol; 2004 Mar; 78(5):2319-26. PubMed ID: 14963128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail.
    Murakami T; Freed EO
    J Virol; 2000 Apr; 74(8):3548-54. PubMed ID: 10729129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail.
    Wyma DJ; Jiang J; Shi J; Zhou J; Lineberger JE; Miller MD; Aiken C
    J Virol; 2004 Apr; 78(7):3429-35. PubMed ID: 15016865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mutation in the human immunodeficiency virus type 1 Gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41.
    Davis MR; Jiang J; Zhou J; Freed EO; Aiken C
    J Virol; 2006 Mar; 80(5):2405-17. PubMed ID: 16474147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.